Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 1010 for “"leukaemia"”.

  1. Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia

    … and is a common treatment for acute myeloid leukaemia (AML). Allo-SCT relies on donor T cells identifying AML cells as foreign and eradicating them, which is known as graft-versus-leukaemia (GvL). Donor T cells recognise AML through interactions between their T cell receptor (TCR) and peptide …

    oxford Repository record for Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia (opens in a new tab)

  2. Features of leukaemia

    Typewritten

    adelaide Repository record for Features of leukaemia (opens in a new tab)

  3. Identifying the DNA binding specificity of mixed lineage leukaemia in leukaemia

    … an aggressive, poor-prognosis subset of acute leukaemia. Although MLL binds unmethylated CpG-island promoters through its CXXC domain, only a subset of these potential sites is occupied in the fusion context. This thesis investigates the determinants of that selectivity across three regulatory …

    oxford Repository record for Identifying the DNA binding specificity of mixed lineage leukaemia in leukaemia (opens in a new tab)

  4. Endogenous Feline Leukaemia Viruses: Their Role in Leukaemia and Resistance to Infection

    This investigation was designed to characterise the expression of enFeLV in vitro and in vivo at both RNA and protein levels in feline cells and tissues because of the potential importance of endogenous virus expression in mediating resistance to infection and participating in genetic …

    glasgow Download PDF for Endogenous Feline Leukaemia Viruses: Their Role in Leukaemia and Resistance to Infection (opens in a new tab)

  5. Leucosis (leukaemia) in childhood

    … Virchow described this disease and called it leukaemia. He differentiated between a splenic leukaemia in which the principle pathological change was in the spleen and a lymphatic leukaemia in which the lymph glands were primarily involved. In 1857 Von Friedrich described the first case of …

    edinburgh Repository record for Leucosis (leukaemia) in childhood (opens in a new tab)

  6. Induction of Graft-Versus-Leukaemia Activity Following Bone Marrow Transplantation for Chronic Myeloid Leukaemia

    … describes the induction of in vitro graft-versus-leukaemia (GVL) activity following bone marrow transplantation (BMT) for chronic myeloid leukaemia (CML).

    glasgow Download PDF for Induction of Graft-Versus-Leukaemia Activity Following Bone Marrow Transplantation for Chronic Myeloid Leukaemia (opens in a new tab)

  7. Radio-Active Phosphorus in Leukaemia

    … is concerned with the response to P32 of chronic leukaemia in humans. Section I outlines the historical basis of classification of the leukaemias, preference being given for a simple working system. The common clinical syndromes are described, followed by a brief account of the main clinical …

    glasgow Download PDF for Radio-Active Phosphorus in Leukaemia (opens in a new tab)

  8. Feline leukaemia virus-specific proteins

    … was concerned with the polypeptides of feline leukaemia virus (FeLV), both the structural polypeptides of the virus particle and putative non-structural proteins which appear in FeLV-infected and transformed cells. In the first part of the work (Chapter Two) it was established that virus …

    glasgow Download PDF for Feline leukaemia virus-specific proteins (opens in a new tab)

  9. Redox signalling in myeloid leukaemia

    … expressed in approximately 90% of acute myeloid leukaemia (AML) patients. Internal tandem duplication of sequences in the juxtamembrane domain of the FLT3 receptor (FLT3-ITD) is the most prevalent FLT3 mutation accounting for 15-35% of AML cases. FLT3-ITD expressing cells produce elevated levels …

    cork Repository record for Redox signalling in myeloid leukaemia (opens in a new tab)

  10. The early stages of leukaemia

    … has been a growing literature on the subject of leukaemia in its earlier stages, and it is becoming apparent that conditions formerly thought to be separate entities, are actually unusual manifestations of a well recognised type. Thus the classification and nomenclature tends to become …

    edinburgh Repository record for The early stages of leukaemia (opens in a new tab)

  11. Isolation and characterisation of inhibitors of leukaemia with translocatins involving the mixed lineage leukaemia oncogene

    Acute lymphoblastic leukaemia is the most common childhood cancer with cure rates of approximately 80%. This success can be attributed to the introduction of risk stratification for patients and employment of intensified treatment regimes for patients with high risk disease. However, the …

    unsw Repository record for Isolation and characterisation of inhibitors of leukaemia with translocatins involving the mixed lineage leukaemia oncogene (opens in a new tab)

  12. Precision medicine in chronic myeloid leukaemia

    … revolutionized the landscape of chronic myeloid leukaemia (CML) therapy and overall survival over the past two decades has dramatically improved, but outcomes remain heterogenous. This thesis demonstrates the importance of exploratory biomarkers for the prediction of the spectrum of responses in …

    adelaide Repository record for Precision medicine in chronic myeloid leukaemia (opens in a new tab)

  13. Polarised secretion of leukaemia inhibitory factor

    Leukaemia inhibitory factor (LIF) is a cytokine that is active on a wide variety of cells. Multiple LIF transcripts have been described. The transcripts LIF-D and LIF-M encode different signal peptides, which in mouse have been associated with differential localisation of the mature protein. LIF-D …

    aston Download PDF for Polarised secretion of leukaemia inhibitory factor (opens in a new tab)

  14. Parthenolide derivatives as potential leukaemia drugs

    Chronic lymphocytic leukaemia (CLL) is a common type of leukaemia and it is frequently diagnosed in Western countries. Current therapy to cure this frequently diagnosed leukaemia is unsatisfactory. Therefore, the search for potential drugs has become an important research topic in recent years. …

    birmingham Download PDF for Parthenolide derivatives as potential leukaemia drugs (opens in a new tab)

  15. Proteasome inhibition in chronic myeloid leukaemia

    CML is treated effectively with TKI, however two key problems remain - the insensitivity of CM HSC to TKI and the emergence of TKI-resistant BCR-ABL mutations. BCR-ABL activity is associated with increased proteasome activity and PI are cytotoxic against CML cell lines. We demonstrate that …

    glasgow Download PDF for Proteasome inhibition in chronic myeloid leukaemia (opens in a new tab)

  16. Isoellipticines: novel compounds for leukaemia treatment

    … a number of different cell types, particularly leukaemia cell lines. We consequently examined the effect of these derivatives in detail on the Acute Myeloid Leukaemia (AML) cell line, MV4-11. Cell cycle analyses revealed that the compounds had a range of distinctive cell cycle effects on MV4-11 …

    cork Repository record for Isoellipticines: novel compounds for leukaemia treatment (opens in a new tab)

  17. Study of the chemotherapy of leukaemia

    … disease one hundred years ago, the treatment of leukaemia has passed through two main phases. During the first fifty years treatment was by chemical agents. A ,large variety underwent clinical trial and some were found to temporarily influence the leukaemic process. Unfortunately many were highly …

    edinburgh Repository record for Study of the chemotherapy of leukaemia (opens in a new tab)

  18. The effect of the bone marrow microenvironment in B acute lymphoblastic leukaemia upon anti-leukaemia T cells

    oxford Restricted access

  19. Graft-versus-leukaemia antigen discovery utilising the bone marrow T cell repertoire in patients with acute myeloid leukaemia

    Acute myeloid leukaemia (AML) is a highly aggressive haematological malignancy for which allogeneic stem cell transplantation (alloSCT) remains the most effective curative therapy. Durable disease control relies on the graft-versus-leukaemia (GvL) effect, where donor-derived T cells eradicate …

    oxford Repository record for Graft-versus-leukaemia antigen discovery utilising the bone marrow T cell repertoire in patients with acute myeloid leukaemia (opens in a new tab)

Page 1 of 51